EUVIMEDEUVIMED entdecken
Open Access

A recurrent missense variant in ITPR3 causes demyelinating Charcot-Marie-Tooth with variable severity

Danique Beijer iD, Maike F Dohrn iD, Adriana Rebelo iD, Matt C Danzi, Bianca Rose Grosz, Melina Ellis, Kishore R Kumar iD, Steve Vucic, Horia Vais, Jillian S Weissenrieder, Olesia Lunko, Usha Paudel und 16 weitere

Brain · 2025

DOI: 10.1093/brain/awae206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2025. Verfasst von Danique Beijer und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Hauptthemen laut MEDLINE: Charcot-Marie-Tooth Disease, Mutation, Missense, Inositol 1,4,5-Trisphosphate Receptors, Pedigree. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Charcot-Marie-Tooth Association, German Research Foundation, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Charcot-Marie-Tooth (CMT) disease is a neuromuscular disorder affecting the peripheral nervous system. The diagnostic yield in demyelinating CMT (CMT1) is typically ∼80%–95%, of which at least 60% is due to the PMP22 gene duplication. The remainder of CMT1 is more genetically heterogeneous. We used whole exome and whole genome sequencing data included in the GENESIS database to investigate novel causal genes and mutations in a cohort of ∼2670 individuals with CMT neuropathy. A recurrent heterozygous missense variant p.Thr1424Met in the recently described CMT gene ITPR3, encoding IP3R3 (inositol 1,4,5-trisphosphate receptor 3), was identified. This previously reported p.Thr1424Met change was present in 33 affected individuals from nine unrelated families from multiple populations, representing an unusual recurrence rate at a mutational hotspot, strengthening the gene-disease relationship (gnomAD v4 allele frequency 1.76 × 10−6). Sanger sequencing confirmed the co-segregation of the CMT phenotype with the presence of the mutation in autosomal dominant and de novo inheritance patterns, including a four-generation family with multiple affected second-degree cousins. Probands from all families presented with slow nerve conduction velocities, matching the diagnostic category of CMT1. Remarkably, we observed a uniquely variable clinical phenotype for age at onset and phenotype severity in p.Thr1424Met carrying patients, even within families. Finally, we present data supportive of a dominant-negative effect of the p.Thr1424Met mutation with associated changes in protein expression in patient-derived cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Charcot-Marie-Tooth DiseaseMutation, MissenseInositol 1,4,5-Trisphosphate ReceptorsPedigreeHumansMaleFemaleAdultMiddle AgedAdolescentYoung AdultSeverity of Illness IndexAgedDemyelinating DiseasesChildPhenotype

Stichwörter der Autor:innen

demyelinating Charcot-Marie-Tooth diseaseinositol 1,4,5-trisphosphatenext-generation sequencing

Substanzen

Inositol 1,4,5-Trisphosphate ReceptorsITPR3 protein, human

Autor:innen und Institutionen

  • Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen 72076, Germany.
  • Department of Neurology, Medical Faculty RWTH Aachen University, Aachen 52074, Germany.
  • Northcott Neuroscience Laboratory ANZAC Research Institute, Sydney Local Health District, School of Medical Sciences, University of Sydney, Sydney, NSW 2139, Australia.
  • Department of Neurology and Molecular Medicine Laboratory, Sydney Medical School, University of Sydney, Concord Hospital, Sydney, NSW 2139, Australia.
  • Brain and Nerve Research Centre, Concord Hospital, Sydney Medical School, University of Sydney, Sydney, NSW 2139, Australia.

ORCID-Profile: Danique Beijer, Maike F Dohrn, Adriana Rebelo, Kishore R Kumar, Christopher J Record, Mary M Reilly, Yi-Chung Lee, Stephan Zuchner

Förderung

  • Charcot-Marie-Tooth Association
  • German Research Foundation
  • NINDS NIH HHS
  • Taiwan National Science and Technology Council
  • National Institutes of Neurological Diseases and Stroke and office of Rare Diseases
  • NIH HHS
  • Wellcome Trust
  • Muscular Dystrophy Association

Zitieren

APA

Beijer, D., Dohrn, M. F., Rebelo, A., Danzi, M. C., Grosz, B. R., Ellis, M., Kumar, K. R., Vucic, S., Vais, H., Weissenrieder, J. S., Lunko, O., Paudel, U., Simpson, L. C., Camarena, V., Raposo, J., Saporta, M., Arcia, Y., Xu, I., Feely, S., …, & Zuchner, S. (2025). A recurrent missense variant in ITPR3 causes demyelinating Charcot-Marie-Tooth with variable severity. Brain. https://doi.org/10.1093/brain/awae206

Vancouver

Beijer D, Dohrn MF, Rebelo A, Danzi MC, Grosz BR, Ellis M, et al. A recurrent missense variant in ITPR3 causes demyelinating Charcot-Marie-Tooth with variable severity. Brain. 2025. doi:10.1093/brain/awae206

BibTeX
@article{Beijer2025,
  author = {Beijer, Danique and Dohrn, Maike F and Rebelo, Adriana and Danzi, Matt C and Grosz, Bianca Rose and Ellis, Melina and Kumar, Kishore R and Vucic, Steve and Vais, Horia and Weissenrieder, Jillian S and Lunko, Olesia and Paudel, Usha and Simpson, Leah C and Camarena, Vladimir and Raposo, Jacquelyn and Saporta, Mario and Arcia, Yeisha and Xu, Isaac and Feely, Shawna and Record, Christopher J and Blake, Julian and Reilly, Mary M and Scherer, Steven S and Kennerson, Marina and Lee, Yi-Chung and Foskett, J Kevin and Shy, Michael E and Zuchner, Stephan},
  title = {A recurrent missense variant in ITPR3 causes demyelinating Charcot-Marie-Tooth with variable severity},
  journal = {Brain},
  year = {2025},
  doi = {10.1093/brain/awae206}
}
Kostenlos starten →